Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Millennium Pharmaceuticals, Inc. (Millennium) is a bio pharmaceutical company that undertakes research, development, and commercialization activities of medicines used for the treatment of cancer. The company develops drugs related to inflammation. Millennium is a subsidiary of Takeda Pharmaceutical Company Limited. The companys lead product, Velcade (bortezomib), is used to treatment multiple myeloma and Mantle Cell Lymphoma. Millennium has 300 projects under way with pipeline products of more than 15 oncology investigational compounds that targets diseases like, growth signaling inhibition, angiogenesis, protein homeostasis, apoptosis, cell cycle inhibition and hormone regulation.

Millennium Pharmaceuticals, Inc. Key Recent Developments:

May 09, 2013: Takeda Announces Resignation Of Millenniums CEO Deborah Dunsire, Integrates Its Research Center
Mar 29, 2013: Millennium And WIN Consortium Partner To Fight Cancer
Mar 29, 2013: Millennium And WIN Consortium Form Partnership To Advance Personalized Cancer Treatments
Aug 09, 2012: Takeda Establishes Development Center In China

Change Currency


Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency


Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.


Contrast settings

Text size settings